Mocetinostat reduced Ctgf by 20% (p < 0.05) and α-SMA expression by 43% (p < 0.01) in fibroblasts incubated with AF-paced medium (Figures 4F,G). The gene discussed is CCN2; the disease is atrial fibrillation.